Lumexa Imaging (NASDAQ:LMRI) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of Lumexa Imaging (NASDAQ:LMRI) from a buy rating to a hold rating in a research report released on Saturday morning.

A number of other equities analysts also recently issued reports on the company. Barclays lowered their price target on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 20th. Weiss Ratings raised Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research note on Thursday, June 25th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Lumexa Imaging presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.

Lumexa Imaging Price Performance

NASDAQ:LMRI opened at $11.74 on Friday. Lumexa Imaging has a 52 week low of $6.45 and a 52 week high of $19.45. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.43. The stock has a market capitalization of $1.13 billion and a PE ratio of -19.90. The stock’s 50-day moving average price is $10.53 and its 200-day moving average price is $10.96.

Insider Activity at Lumexa Imaging

In related news, Director Brett Brodnax purchased 35,000 shares of Lumexa Imaging stock in a transaction that occurred on Tuesday, May 19th. The stock was purchased at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the transaction, the director directly owned 62,027 shares in the company, valued at approximately $449,695.75. This trade represents a 129.50% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Lumexa Imaging

Several large investors have recently bought and sold shares of the company. Assetmark Inc. purchased a new position in shares of Lumexa Imaging in the fourth quarter valued at approximately $36,000. Geode Capital Management LLC purchased a new stake in Lumexa Imaging in the 4th quarter valued at $1,548,000. Seven Grand Managers LLC purchased a new stake in shares of Lumexa Imaging in the fourth quarter valued at about $11,942,000. Goldman Sachs Group Inc. acquired a new stake in shares of Lumexa Imaging during the 4th quarter worth approximately $18,870,000. Finally, TD Asset Management Inc acquired a new stake in Lumexa Imaging during the fourth quarter worth $1,264,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).